Grifols, S.A. (BME:GRF)
Spain · Delayed Price · Currency is EUR 10.66
-0.06 (-0.51%)
Oct 27, 2026, 11:59 AM CET
Grifols Market Cap
Grifols has a market cap or net worth of €6.34 billion as of October 26, 2026. It is the 2,745th most valuable company in the world and the 25th biggest in Spain. Its market cap has decreased by 7.95% in one year.
Market Cap
6.34B
Enterprise Value
17.60B
Revenue
7.42B
Global Rank
Country Rank
#25 Spain
PE Ratio
16.15
ChartMarket Cap Chart
Since May 18, 2006, Grifols's market cap has increased from 729.00M to 6.34B, an increase of 769.98%. That is a compound annual growth rate of 11.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2026 | 6.34B | -2.99% |
| Dec 31, 2025 | 6.54B | 15.08% |
| Dec 31, 2024 | 5.68B | -38.46% |
| Dec 29, 2023 | 9.23B | 40.77% |
| Dec 30, 2022 | 6.56B | -32.97% |
| Dec 30, 2021 | 9.78B | -30.92% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Laboratorios Farmaceuticos Rovi | 3.08B |
| Almirall | 2.26B |
| Faes Farma | 1.44B |
| Pharma Mar | 1.20B |
| Clínica Baviera | 862.58M |
| Prim, S.A. | 214.30M |
| Laboratorio Reig Jofre | 211.76M |
| Oryzon Genomics | 204.91M |